semaglutide and bowel obstruction Due to Can a patient who developed

Opioid use may worsen gastric retention Higher prevalence of recent opioid use in the high RGC group Suggests an additive effect on gastric motility No difference in indication or duration of therapy Whether patients used GLP-1 RAs for diabetes or weight loss did not affect risk Duration of therapy was not a significant predictor Interpretation Withholding 7.5 days higher risk of retained gastric contents Fasting 21.3 hours strongest predictor of high RGC These thresholds optimize sensitivity and specificity for detecting risk

This can lead to significant weight loss and improved metabolic health

Supplements That Support GLP-1 Naturally via the Gut Several dietary and supplemental strategies can enhance GLP-1 secretion via the microbiome: Prebiotics Dietary fibers like inulin, resistant starch, and galacto-oligosaccharides (GOS) fuel beneficial bacteria and increase SCFA production, which in turn promotes GLP-1 release

& Manchester, L

Weight loss itself may theoretically alter thermoregulation as adipose tissue provides insulation and affects heat dissipation